NervGen Pharma Corp. announced that Adam Rogers has been appointed to NervGen's Board of Directors. Adam Rogers, MD is a Principal of PFP Biosciences Holdings and a board-certified ophthalmologist specializing in diseases and surgery of the retina and vitreous.

Dr. Rogers co-founded Hemera Biosciences in 2010. He assumed the role of Chief Executive Officer in 2017 and oversaw all aspects of the company until the Hemera assets were acquired in December 2020 by Janssen Pharmaceuticals, a subsidiary of Johnson &Johnson. Dr. Rogers graduated from Emory University College and Emory School of Medicine.

From 2001 to 2020 he served as an Assistant Professor of Ophthalmology at the New England Eye Center of Tufts Medical Center (Boston, MA). Dr. Rogers has published 25 articles in peer reviewed journals and co-authored two textbooks and numerous chapters in major ophthalmic textbooks. Since 2007 he has served on the board of One Family Inc. He is a member of the Emory University Board of Trustees.